M&T Bank Corporation Announces Fourth Quarter Common Stock Dividend

BUFFALO, N.Y., Nov. 18, 2025 /PRNewswire/ — M&T Bank Corporation (“M&T”) (NYSE:MTB) announced that it has declared a quarterly cash dividend of $1.50 per share on its common stock. The dividend will be payable December 31, 2025, to shareholders of…

Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy

SYDNEY, Nov. 18, 2025 /PRNewswire/ — Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized single-patient expanded access protocol combining paxalisib with pembrolizumab…

DuPont Announces Early Results of Tender Offer for Senior Notes

WILMINGTON, Del., Nov. 18, 2025 /PRNewswire/ — DuPont (NYSE: DD) announced today the early results of its previously announced tender offer (the “Tender Offer”) to purchase for cash up to $739,256,000 aggregate principal amount (the “Maximum Tender Amount”) of its…

TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference

ANDOVER, Mass., Nov. 18, 2025 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team…